Analyzing Tempus AI (TEM) and Its Competitors

Tempus AI (NASDAQ:TEM) is one of 120 publicly-traded companies in the “Computer programming, data processing, & other computer related” industry, but how does it contrast to its peers? We will compare Tempus AI to similar businesses based on the strength of its dividends, analyst recommendations, institutional ownership, valuation, risk, profitability and earnings.

Analyst Recommendations

This is a summary of recent ratings for Tempus AI and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	0	6	7	0	2.54
Tempus AI Competitors	1317	5234	11570	353	2.59

Tempus AI presently has a consensus price target of $63.42, indicating a potential upside of 2.35%. As a group, “Computer programming, data processing, & other computer related” companies have a potential upside of 18.92%. Given Tempus AI’s peers stronger consensus rating and higher possible upside, analysts plainly believe Tempus AI has less favorable growth aspects than its peers.

Profitability

This table compares Tempus AI and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tempus AI	N/A	N/A	-111.38%
Tempus AI Competitors	-138.86%	-18.64%	-3.29%

Earnings & Valuation

This table compares Tempus AI and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Tempus AI	$803.32 million	-$289.81 million	-7.94
Tempus AI Competitors	$11.64 billion	$2.53 billion	-35,284.35

Tempus AI’s peers have higher revenue and earnings than Tempus AI. Tempus AI is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Insider and Institutional Ownership

24.2% of Tempus AI shares are held by institutional investors. Comparatively, 48.7% of shares of all “Computer programming, data processing, & other computer related” companies are held by institutional investors. 27.6% of Tempus AI shares are held by company insiders. Comparatively, 17.3% of shares of all “Computer programming, data processing, & other computer related” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Tempus AI peers beat Tempus AI on 8 of the 12 factors compared.

About Tempus AI

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.